Cold & Cough Remedies - Algeria

  • Algeria
  • In Algeria, the revenue generated in the Cold & Cough Remedies market market in 2024 amounts to US$98.46m.
  • It is projected that the market will experience an annual growth rate of 3.88% from 2024 to 2029 (CAGR 2024-2029).
  • When compared globally, the in the United States stands out as the country with the highest revenue in this market, amounting to US$11,190.00m in 2024.
  • Taking into account the total population figures, in Algeria, the per person revenue generated in 2024 is US$2.13.
  • Algeria's cold and cough remedies market is experiencing a surge in demand due to the country's harsh winter climate.

Key regions: Australia, Japan, India, Brazil, Canada

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cold & Cough Remedies market in Algeria has been experiencing significant growth in recent years.

Customer preferences:
Algerian consumers are increasingly seeking over-the-counter remedies for cold and cough symptoms. This shift in preference can be attributed to several factors. Firstly, there is a growing awareness among consumers about the efficacy and safety of over-the-counter medications. They are more willing to self-diagnose and self-medicate, especially for common ailments like cold and cough. Secondly, the convenience and accessibility of over-the-counter remedies have made them a popular choice among consumers. They can easily purchase these products from pharmacies and supermarkets without the need for a prescription. Lastly, the affordability of over-the-counter remedies compared to prescription medications is another factor driving customer preferences in Algeria.

Trends in the market:
One of the key trends in the Cold & Cough Remedies market in Algeria is the increasing demand for natural and herbal remedies. Consumers are becoming more health-conscious and are seeking products that are perceived to be safer and have fewer side effects. This trend is in line with the global shift towards natural and organic products. Manufacturers are capitalizing on this trend by introducing a wide range of natural and herbal remedies in the market. These products often contain ingredients such as honey, ginger, and herbal extracts known for their soothing and healing properties. The demand for these products is expected to continue growing as consumers become more educated about the benefits of natural remedies.

Local special circumstances:
Algeria has a high prevalence of respiratory diseases, including asthma and chronic obstructive pulmonary disease (COPD). These conditions increase the demand for cold and cough remedies as patients seek relief from their symptoms. Additionally, the country experiences seasonal variations in temperature, which can contribute to the spread of cold and flu viruses. This further drives the demand for cold and cough remedies during certain times of the year.

Underlying macroeconomic factors:
The growth of the Cold & Cough Remedies market in Algeria is also influenced by underlying macroeconomic factors. The country has been experiencing steady economic growth, which has resulted in an increase in disposable income among consumers. This has enabled them to spend more on healthcare products, including over-the-counter remedies. Furthermore, the government has been investing in the healthcare sector, improving access to healthcare services and increasing awareness about self-medication. These factors have contributed to the growth of the Cold & Cough Remedies market in Algeria.In conclusion, the Cold & Cough Remedies market in Algeria is experiencing growth due to changing customer preferences, including a shift towards over-the-counter remedies and the demand for natural and herbal products. The high prevalence of respiratory diseases and seasonal variations in temperature also contribute to the market growth. Additionally, underlying macroeconomic factors such as economic growth and government investments in healthcare are driving the market expansion.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)